Income Statement (TTM)
Aethlon Medical, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Change (%) | 34.09 | -20.74 | 20.02 | 16.68 | -65.84 | -6.70 | -44.86 | -81.36 | -56.62 | 4,278.20 | 0.00 | 0.00 | 0.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | ||||||||||||||
| Change (%) | ||||||||||||||
| % of Revenue | ||||||||||||||
| Gross Operating Profit | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Change (%) | 34.09 | -20.74 | 20.02 | 16.68 | -65.84 | -6.70 | -44.86 | -81.36 | -56.62 | 4,278.20 | 0.00 | 0.00 | 0.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 6 | 8 | 9 | 9 | 10 | 9 | 11 | 11 | 13 | 13 | 12 | 13 | 12 | 12 |
| Change (%) | 27.53 | 3.72 | 9.59 | 3.93 | -5.38 | 16.28 | 6.31 | 13.40 | 2.34 | -5.65 | 4.03 | -3.79 | -1.23 | |
| % of Revenue | 1,042.32 | 991.31 | 1,297.31 | 1,184.55 | 1,055.13 | 2,922.79 | 3,642.53 | 7,022.69 | 42,724.57 | 100,789.42 | 2,172.05 | 2,259.48 | 2,173.87 | 2,147.16 |
| R&D | ||||||||||||||
| Change (%) | ||||||||||||||
| % of Revenue | ||||||||||||||
| OpEx | 6 | 8 | 9 | 9 | 10 | 9 | 11 | 11 | 13 | 13 | 12 | 13 | 12 | 12 |
| Change (%) | 27.53 | 3.72 | 9.59 | 3.93 | -5.38 | 16.28 | 6.31 | 13.40 | 2.34 | -5.65 | 4.03 | -3.79 | -1.23 | |
| % of Revenue | 1,042.32 | 991.31 | 1,297.31 | 1,184.55 | 1,055.13 | 2,922.79 | 3,642.53 | 7,022.69 | 42,724.57 | 100,789.42 | 2,172.05 | 2,259.48 | 2,173.87 | 2,147.16 |
| Operating Income | -6 | -7 | -8 | -9 | -9 | -9 | -10 | -11 | -13 | -13 | -12 | -12 | -12 | -12 |
| Change (%) | 26.83 | 6.47 | 8.72 | 2.76 | 0.95 | 17.09 | 7.75 | 14.77 | 2.48 | -9.90 | 4.22 | -3.96 | -1.29 | |
| % of Revenue | -942.32 | -891.31 | -1,197.31 | -1,084.55 | -955.13 | -2,822.79 | -3,542.53 | -6,922.69 | -42,624.58 | -100,689.46 | -2,072.05 | -2,159.48 | -2,073.87 | -2,047.16 |
| Interest Expense | -0 | 0 | ||||||||||||
| Change (%) | -100.00 | |||||||||||||
| % of Revenue | -0.02 | 0.00 | ||||||||||||
| Net Income | -6 | -7 | -8 | -9 | -9 | -9 | -10 | -11 | -13 | -13 | -12 | -12 | -12 | -12 |
| Change (%) | 28.07 | 6.48 | 8.71 | 2.77 | 0.94 | 17.11 | 7.76 | 16.05 | 2.47 | -9.88 | 3.13 | -6.25 | 5.32 | |
| % of Revenue | -932.51 | -890.65 | -1,196.58 | -1,083.81 | -954.58 | -2,820.96 | -3,540.90 | -6,920.18 | -43,085.30 | -101,768.30 | -2,094.89 | -2,160.45 | -2,025.49 | -2,133.18 |
Source: Capital IQ
